ArticleInternational journal of molecular sciences2023

A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab.

Iyad Kobeissi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.